Evidence map›Paper›PMID 40291086›Full record

ArticleProceedings (Baylor University. Medical Center)2025

Characteristics and outcomes of observed versus resected pancreatic neuroendocrine tumors.

Caroline Breit, Bobby Dow, Masen Ragsdale, Rachel Jefferies, Pallavi Patil, Catherine H Davis

Abstract read
In one paragraph

Article in Proceedings (Baylor University. Medical Center), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Pancreatic neuroendocrine tumors: studying real-world outcomes.Proceedings (Baylor University. Medical Center) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Caroline BreitDivision of Surgical Oncology, Baylor University Medical Center, Dallas, Texas, USA.ORCID https://orcid.org/0009-0005-0409-2330
Bobby DowDivision of Surgical Oncology, Baylor University Medical Center, Dallas, Texas, USA.
Masen RagsdaleDivision of Surgical Oncology, Baylor University Medical Center, Dallas, Texas, USA.
Rachel JefferiesDivision of Surgical Oncology, Baylor University Medical Center, Dallas, Texas, USA.
Pallavi PatilDepartment of Pathology, Baylor University Medical Center, Dallas, Texas, USA.
Catherine H DavisDivision of Surgical Oncology, Baylor University Medical Center, Dallas, Texas, USA.ORCID https://orcid.org/0000-0002-0976-8054

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Pancreatic neuroendocrine tumors (pNETs) are a rare group of tumors with a wide range of clinical presentations. pNETs may present as incidentally discovered slow-growing tumors or as more aggressive tumors with metastatic potential. The mainstay of treatment is surgical resection; however, some have argued that observation can be considered for small, nonfunctional tumors. The objective of this study was to compare patients with pNETs who underwent initial resection versus observation to better understand tumor characteristics that favor either treatment approach. Methods: A retrospective review was performed of patients diagnosed with pNETs at a tertiary referral center from 2018 to 2023. Information on the patient and tumor, disease and treatment course, and outcomes was collected. Results: Forty-three patients were included in the study; 33% underwent initial resection, 37% underwent observation, and 30% underwent surgical resection following a period of observation (delayed resection). Patients who underwent initial resection were more likely to be younger with fewer comorbidities and have symptomatic or functional tumors. Patients with tumors >2 cm were more likely to have a postoperative complication. In a subgroup of patients with incidentally discovered tumors ≤2 cm, 33% underwent delayed resection and did not experience any postoperative complications; 66% underwent observation, and none had progression of their disease over the follow-up period of 17 months. Conclusion: While surgical resection remains the mainstay of treatment for pNETs, a period of observation in select individuals with small, incidentally discovered pNETs may also be considered safe. Management with surgical resection or initial observation must be an individualized decision and may be optimally supported with formal multidisciplinary tumor board discussion.

Indexed as

Neuroendocrine tumorobservationpancreaspancreatic neuroendocrine tumorpNET

Identifiers

PMID40291086
PMCPMC12026034

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.